1 – 8 of 8
      - show: 10
 - |
 - sort: year (new to old)
 
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2021
 - 
                        Mark
        Development of a core outcome domain set for clinical research on capillary malformations (the COSCAM project)
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        European Task Force on Atopic Dermatitis : position on vaccination of adult patients with atopic dermatitis against COVID-19 (SARS-CoV-2) being treated with systemic medication and biologics
    
    
- Contribution to journal › Letter
 
 - 
                        Mark
        Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin diseases – practical recommendations. A position statement of ETFAD with external experts
    
    
- Contribution to journal › Letter
 
 - 2020
 - 
                        Mark
        TREatment of ATopic eczema (TREAT) Registry Taskforce : protocol for a European safety study of dupilumab and other systemic therapies in patients with atopic eczema
    
    
- Contribution to journal › Article
 
 - 2018
 - 
                        Mark
        Report from the fifth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
    
    
- Contribution to journal › Article
 
 - 2017
 - 
                        Mark
        Patient-Oriented Eczema Measure (POEM), a core instrument to measure symptoms in clinical trials : A Harmonising Outcome Measures for Eczema (HOME) statement
    
    
- Contribution to journal › Article
 
 - 
                        Mark
        Evaluation of the measurement properties of symptom measurement instruments for atopic eczema : A systematic review
    
    
- Contribution to journal › Article
 
 - 2016
 - 
                        Mark
        Report from the fourth international consensus meeting to harmonize core outcome measures for atopic eczema/dermatitis clinical trials (HOME initiative)
    
    
- Contribution to journal › Article